UMECO Group – A strong distribution partner for Viromed in Asia
In April 2025, Viromed entered into an exclusive distribution agreement with UMECO Group (“UMECO”) for the commercialization of ViroCAP@ and PulmoPlas@ (link to press release), thereby opening up the Asian markets for these innovative cold plasma medical devices.
Founded in 1986, UMECO is now a leading provider of innovative technologies in the fields of regenerative medicine, dermatology, plus laser and energy-based therapies. The company has successfully pioneered numerous global brands in Korea and Asia, including SkinCeuticals, Obagi, Sesderma, RegenLab, Caregen, Revivre, and Regenera Activa.
In addition, UMECO was involved in the worldwide introduction of the first Q-switch ruby laser, the first Er:YAG laser and the first copper vapor laser in Asia. Photodynamic therapies (PDT), carbon laser treatments for skin rejuvenation and cell-based therapies such as Regenera Activa or Cytokine Complex Mesotherapy were also presented and established at international specialist congresses at an early stage.
The UMECO Group has a strong global partner network: In Europe, the company works closely with partners such as Alma Lasers, Fotona, Quanta System, Brera Medical Technologies and Dornier. In Asia, UMECO works with leading organizations such as NeoAsia (Singapore/Taiwan), Dmark (Philippines), Reyoung Gel (China) and Ritsubi (Japan). In addition, there are partners in Israel such as Pollogen and Venus Concept, plus further partners worldwide.
UMECO also has its sights set on future medical solutions: these include non-invasive plasma therapies for pain, innovative plasma applications in oncology and lung medicine, microwave-based hyperthermia and diagnostic technologies such as SQUID-based quantum conductivity for high-precision imaging.
With a broad portfolio of laser and plasma medical devices, skin care devices, skin boosters and cosmeceuticals, UMECO is actively shaping the future of the global health and beauty industry.
The UMECO Group is the ideal distribution partner for Viromed in Asia, due to the company’s international expertise and sales reach, as well as its clear vision for the next generation of medical solutions.